| Not Yet Recruiting | A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epiderm Breast Neoplasms | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) Alopecia Areata | Phase 2 | 2026-04-14 |
| Not Yet Recruiting | A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | 2026-04-14 |
| Not Yet Recruiting | A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | A Study of LY4515100 in Participants With Pain Following Third Molar Removal Acute Pain, Molar, Molar, Third | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease Colitis, Ulcerative, Crohn Disease | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Crohn Disease | Phase 2 | 2026-04-01 |
| Recruiting | A Study of [14C]-LY4064809 in Healthy Participants Healthy | Phase 1 | 2026-03-27 |
| Recruiting | A Study of Brenipatide in Participants With Opioid Use Disorder Opioid Use Disorder | Phase 2 | 2026-03-12 |
| Recruiting | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymph Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic | Phase 4 | 2026-03-09 |
| Recruiting | A Study of Olomorasib (LY3537982) in Healthy Participants Healthy | Phase 1 | 2026-03-02 |
| Not Yet Recruiting | A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity Obesity, Overweight | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Alzheimer's Disease, Early Alzheimer's Disease, Memory Problems | — | 2026-03-01 |
| Not Yet Recruiting | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obes Diabetes Mellitus, Type 2, Obesity, Overweight | Phase 4 | 2026-03-01 |
| Not Yet Recruiting | A Study of Mirikizumab Solution (LY3074828) in Healthy Participants Healthy | Phase 1 | 2026-03-01 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Rena Kidney Disease, Renal Insufficiency Chronic, Kidney Failure, Chronic | Phase 1 | 2026-02-24 |
| Recruiting | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropath Diabetic Peripheral Neuropathic Pain | Phase 2 | 2026-02-16 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight Sleep Apnea, Obstructive, Obesity, Overweight | Phase 3 | 2026-02-10 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incr Overweight, Obesity | Phase 3 | 2026-02-10 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants Hepatic Insufficiency | Phase 1 | 2026-02-10 |
| Recruiting | A Study of Brenipatide in Adult Participants With Schizophrenia Schizophrenia | Phase 2 | 2026-02-10 |
| Recruiting | A Study of Brenipatide in Adult Participants With Major Depressive Disorder Depressive Disorder, Major | Phase 3 | 2026-02-09 |
| Recruiting | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or O Osteoarthritis, Overweight or Obesity | Phase 3 | 2026-02-09 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes Obesity, Overweight | Phase 3 | 2026-02-06 |
| Recruiting | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Diabetes Mellitus, Type 1 | Phase 3 | 2026-02-05 |
| Recruiting | A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheum Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis | Phase 1 | 2026-02-04 |
| Recruiting | A Study of Remternetug (LY3372993) in Healthy Chinese Participants Healthy | Phase 1 | 2026-01-31 |
| Recruiting | A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight Obesity, Overweight | Phase 3 | 2026-01-24 |
| Recruiting | A Study of LY4515100 in Healthy Participants Healthy | Phase 1 | 2026-01-15 |
| Recruiting | A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid Diabetes Mellitus, Type 2, Overweight, Obesity | Phase 1 | 2026-01-14 |
| Active Not Recruiting | A Study of LY4064809 in Healthy Adult Participants Healthy Participants | Phase 1 | 2026-01-12 |
| Recruiting | A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults Diabetes Mellitus, Type 1 | Phase 3 | 2026-01-12 |
| Active Not Recruiting | A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retentio Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-12-29 |
| Recruiting | A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer Neoplasms, Healthy | Phase 1 | 2025-12-22 |
| Recruiting | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Brea Breast Neoplasms, Neoplasm Metastasis | Phase 3 | 2025-12-22 |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Overweight, Obesity | Phase 3 | 2025-12-15 |
| Recruiting | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis | Phase 3 | 2025-12-12 |
| Recruiting | A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia Severe Hypertriglyceridemia | Phase 2 | 2025-12-08 |
| Recruiting | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis Healthy, Rheumatoid Arthritis (RA) | Phase 1 | 2025-12-02 |
| Recruiting | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular D Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease | Phase 3 | 2025-12-01 |
| Not Yet Recruiting | A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease Cognitive Dysfunction, Memory Disorders | — | 2025-12-01 |
| Recruiting | A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With C Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions | Phase 2 | 2025-11-28 |
| Recruiting | A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) Bipolar Disorder | Phase 2 | 2025-11-24 |
| Recruiting | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Witho Obesity | Phase 4 | 2025-11-24 |
| Recruiting | A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy Overweight, Obesity | Phase 1 | 2025-11-18 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight Obesity, Overweight | Phase 3 | 2025-11-17 |
| Recruiting | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Ulcerative Colitis | Phase 2 | 2025-11-10 |
| Active Not Recruiting | A Study of How the Body Absorbs LY3537031 Healthy | Phase 1 | 2025-11-03 |
| Recruiting | A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse Smoking | Phase 2 | 2025-11-03 |
| Recruiting | Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Peripheral Arterial Disease | Phase 3 | 2025-10-31 |
| Recruiting | A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity Healthy, Obesity, Overweight | Phase 1 | 2025-10-27 |
| Completed | A Study of LY4064809 in Healthy Adult Chinese Participants Healthy | Phase 1 | 2025-10-24 |
| Recruiting | A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms | Phase 3 | 2025-10-22 |
| Recruiting | A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Seve Asthma | Phase 2 | 2025-10-22 |
| Recruiting | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms | Phase 1 | 2025-10-22 |
| Recruiting | A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mi Healthy, Hepatic Insufficiency | Phase 1 | 2025-10-20 |
| Recruiting | A Study of Brenipatide in Participants With Alcohol Use Disorder Alcohol Use Disorder | Phase 3 | 2025-10-16 |
| Recruiting | A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesit Obesity, Overweight, Diabetes Mellitus, Type 2 | Phase 2 | 2025-10-16 |
| Recruiting | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder Alcohol Use Disorder | Phase 3 | 2025-10-15 |
| Recruiting | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease ( Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 3 | 2025-10-15 |
| Recruiting | A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin Diabetes Mellitus, Type 2 | Phase 2 | 2025-10-13 |
| Recruiting | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight Urinary Incontinence,Stress | Phase 3 | 2025-09-30 |
| Active Not Recruiting | A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participant Renal Impairment, Healthy, Renal Insufficiency | Phase 1 | 2025-09-18 |
| Completed | A Study of Olomorasib (LY3537982) in Healthy Japanese Participants Healthy | Phase 1 | 2025-09-16 |
| Recruiting | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Osteoarthritis | Phase 3 | 2025-09-15 |
| Recruiting | Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) | Phase 3 | 2025-09-02 |
| Recruiting | A Study of LY4064912 in Healthy Participants and With Overweight or Obesity Overweight or Obesity, Healthy | Phase 1 | 2025-08-28 |
| Recruiting | Epidemiology and Biomarker Study in Alzheimer's Disease Alzheimer Disease | Phase 3 | 2025-08-25 |
| Recruiting | A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patien Subjective Cognitive Impairment | N/A | 2025-08-22 |
| Recruiting | A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Functi Renal Insufficiency | Phase 1 | 2025-08-18 |
| Completed | A Study of LY3985863 in Healthy Participants Healthy | Phase 1 | 2025-08-11 |
| Active Not Recruiting | Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, B-cell Lymphoma | Phase 2 | 2025-08-07 |
| Recruiting | A Study of LY4257496 in Participants With Cancer (OMNIRAY) Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm | Phase 1 | 2025-08-06 |
| Recruiting | A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | 2025-08-05 |
| Recruiting | A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | 2025-07-30 |
| Recruiting | A Study of LY4175408 in Participants With Advanced Cancer Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms | Phase 1 | 2025-07-28 |
| Completed | A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 1 | 2025-07-25 |
| Recruiting | A Study of LY4088044 in Healthy Participants Healthy | Phase 1 | 2025-07-24 |
| Terminated | A Study of LY3549492 in Healthy Weight Adult Participants Healthy | Phase 2 | 2025-07-21 |
| Recruiting | A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants Healthy | Phase 1 | 2025-07-11 |
| Recruiting | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Dise Crohn's Disease, Obesity or Overweight | Phase 3 | 2025-06-26 |
| Recruiting | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Act Ulcerative Colitis, Obesity or Overweight | Phase 3 | 2025-06-26 |
| Completed | A Study of Remternetug (LY3372993) in Healthy Participants Healthy | Phase 1 | 2025-06-24 |
| Completed | A Study of [14C]-LY4065967 in Healthy Participants Healthy | Phase 1 | 2025-06-23 |
| Terminated | A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes Obesity, Overweight, Type 2 Diabetes | Phase 2 | 2025-06-19 |
| Recruiting | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) Atopic Dermatitis | Phase 4 | 2025-06-16 |
| Recruiting | A Study of LY3981314 in Healthy Participants Healthy | Phase 1 | 2025-06-09 |
| Active Not Recruiting | A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide t Type 2 Diabetes Mellitus | Phase 1 | 2025-06-06 |
| Recruiting | A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participan Diabetes Mellitus, Insulin Sensitivity | Phase 1 | 2025-06-02 |
| Recruiting | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain Obesity, Overweight, Chronic Low Back Pain (CLBP) | Phase 3 | 2025-05-29 |
| Recruiting | A Study of LY3867070 in Healthy Participants Healthy | Phase 1 | 2025-05-27 |
| Withdrawn | A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With O Obesity, Overweight | Phase 2 | 2025-05-23 |
| Recruiting | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma | Phase 4 | 2025-05-20 |
| Recruiting | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Smal Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma | Phase 4 | 2025-05-20 |
| Recruiting | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes Obesity, Overweight, Type 2 Diabetes | Phase 3 | 2025-05-19 |
| Recruiting | A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1 | 2025-05-16 |
| Recruiting | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Obesity, Overweight | Phase 3 | 2025-05-15 |
| Recruiting | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Typ Obesity, Overweight, Type 2 Diabetes | Phase 3 | 2025-05-15 |
| Recruiting | A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY40 Healthy, Cancer | Phase 1 | 2025-05-13 |
| Active Not Recruiting | A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight Type 1 Diabetes, Obesity, Overweight | Phase 3 | 2025-05-12 |
| Completed | A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Partici Healthy, Type 2 Diabetes Mellitus (T2D) | Phase 1 | 2025-05-07 |
| Completed | A Study of LY4268989 (MORF-057) in Healthy Participants Healthy | Phase 1 | 2025-05-01 |
| Recruiting | A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (A Hypertension | Phase 3 | 2025-04-30 |
| Recruiting | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweigh Hypertension | Phase 3 | 2025-04-30 |
| Recruiting | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweigh Hypertension, Overweight or Obesity | Phase 3 | 2025-04-30 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overwei Type 1 Diabetes, Obesity, Overweight | Phase 3 | 2025-04-25 |
| Recruiting | A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function Liver Dysfunction, Healthy | Phase 1 | 2025-04-23 |
| Recruiting | A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type Healthy, Overweight, Obesity | Phase 1 | 2025-04-23 |
| Completed | A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight Obesity, Overweight | Phase 1 | 2025-04-21 |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Atopic Hand and Foot Dermatitis | Phase 3 | 2025-04-21 |
| Completed | A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesi Overweight, Obesity | Phase 1 | 2025-04-09 |
| Active Not Recruiting | Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Bod Healthy Participants | Phase 1 | 2025-04-08 |
| Recruiting | A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutid Type 2 Diabetes | Phase 2 | 2025-03-28 |
| Recruiting | Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresect Carcinoma, Non-Small-Cell Lung | Phase 3 | 2025-03-27 |
| Completed | A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants Healthy | Phase 1 | 2025-03-25 |
| Recruiting | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439 Psoriasis, Overweight or Obesity | Phase 4 | 2025-03-19 |
| Active Not Recruiting | A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2025-03-19 |
| Recruiting | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Ac Psoriatic Arthritis, Overweight or Obesity | Phase 4 | 2025-03-06 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity Obesity | Phase 3 | 2025-03-05 |
| Recruiting | A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease Parkinson Disease | Phase 1 | 2025-02-18 |
| Completed | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight Obesity, Overweight | Phase 1 | 2025-02-17 |
| Active Not Recruiting | A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder Alcohol Use Disorder | Phase 2 | 2025-02-06 |
| Completed | To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants Healthy | Phase 1 | 2025-02-03 |
| Recruiting | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus ( Type 2 Diabetes | Phase 3 | 2025-01-10 |
| Completed | A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants Healthy | Phase 1 | 2024-12-13 |
| Completed | A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants Healthy | Phase 1 | 2024-12-06 |
| Completed | A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants Hepatic Insufficiency, Healthy | Phase 1 | 2024-12-06 |
| Completed | A Study of LY4060874 in Healthy Participants Healthy Participants | Phase 1 | 2024-12-02 |
| Recruiting | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Obesity, Overweight | Phase 3 | 2024-11-18 |
| Recruiting | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorb Obesity, Overweight | Phase 3 | 2024-11-18 |
| Active Not Recruiting | A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesi Obesity, Overweight | Phase 2 | 2024-11-13 |
| Active Not Recruiting | A Study of LY4005130 in Healthy Participants Healthy | Phase 1 | 2024-11-08 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity Obesity | Phase 3 | 2024-11-01 |
| Recruiting | A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) Alzheimer Disease, Healthy | Phase 1 | 2024-10-29 |
| Completed | A Study of [14C]-LY3866288 in Healthy Participants Healthy | Phase 1 | 2024-10-28 |
| Active Not Recruiting | A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With Glioma | Phase 2 | 2024-10-25 |
| Active Not Recruiting | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) Alzheimer's Disease | Phase 3 | 2024-10-24 |
| Completed | A Study of LY4065967 in Healthy Japanese Participants Healthy | Phase 1 | 2024-10-22 |
| Active Not Recruiting | A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight OSA, Overweight or Obesity | Phase 3 | 2024-10-22 |
| Active Not Recruiting | A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Obesity, Overweight | Phase 2 | 2024-10-21 |
| Active Not Recruiting | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2024-10-21 |
| Completed | A Study of LY3866288 in Healthy Participants Healthy | Phase 1 | 2024-10-17 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan Type 2 Diabetes | Phase 4 | 2024-10-11 |
| Recruiting | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 2 | 2024-10-10 |
| Completed | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 1 | 2024-10-10 |
| Withdrawn | Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease Chronic Kidney Disease | Phase 2 | 2024-10-09 |
| Recruiting | A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Particip Alzheimer Disease | — | 2024-10-07 |
| Active Not Recruiting | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Psoriasis, Obesity | Phase 3 | 2024-09-30 |
| Active Not Recruiting | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overw Psoriatic Arthritis, Obesity | Phase 3 | 2024-09-24 |
| Active Not Recruiting | A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, Obesity, Overweight | Phase 2 | 2024-09-20 |
| Recruiting | A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1 | 2024-09-19 |
| Completed | A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overw Obesity, Overweight | Phase 3 | 2024-09-13 |
| Recruiting | MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2024-09-12 |
| Active Not Recruiting | A Study of LY3537031 in Overweight, Obese, and Healthy Participants Overweight, Obesity | Phase 1 | 2024-09-05 |
| Active Not Recruiting | A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease Alzheimer Disease | Phase 2 | 2024-08-26 |
| Active Not Recruiting | Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy Neuropathic Pain, Distal Sensory Polyneuropathy | Phase 2 | 2024-08-22 |
| Completed | A Study of LY3532226 in Participants With Obesity Obesity | Phase 1 | 2024-08-16 |
| Recruiting | A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease Alzheimer Disease | Phase 1 | 2024-08-15 |
| Completed | A Study of Subcutaneous Injection in Healthy Participants Healthy | N/A | 2024-07-22 |
| Recruiting | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor | Phase 1 | 2024-07-01 |
| Completed | A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or O Healthy, Obese, Overweight | Phase 1 | 2024-06-24 |
| Completed | A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants Healthy | Phase 1 | 2024-06-24 |
| Completed | A First-In-Human Study of LY3985297 in Healthy Participants Healthy | Phase 1 | 2024-06-07 |
| Completed | Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2024-06-04 |
| Recruiting | A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) Obesity, Weight Gain | Phase 3 | 2024-06-03 |
| Recruiting | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms | Phase 1 | 2024-05-20 |
| Recruiting | A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) Healthy, Type 1 Diabetes Mellitus | Phase 1 | 2024-05-15 |
| Completed | A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants Healthy | Phase 1 | 2024-05-06 |
| Active Not Recruiting | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obe Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | Phase 3 | 2024-04-30 |
| Recruiting | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Phase 3 | 2024-04-29 |
| Recruiting | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) Perennial Allergic Rhinitis (PAR) | Phase 3 | 2024-04-26 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity | Phase 2 | 2024-04-24 |
| Active Not Recruiting | A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderat Atopic Dermatitis | Phase 3 | 2024-04-24 |
| Completed | A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India Diabetes Mellitus, Type 2 | Phase 4 | 2024-04-18 |
| Completed | A Study of LY3841136 in Japanese Participants With Obesity or Overweight Obesity, Overweight | Phase 1 | 2024-04-15 |
| Completed | Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Diabetes Type 2 | Phase 3 | 2024-04-10 |
| Active Not Recruiting | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cance Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma | Phase 1 | 2024-04-03 |
| Completed | A Study of LY3841136 in Overweight and Obese Participants Obesity, Overweight | Phase 1 | 2024-04-03 |
| Completed | A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants Healthy | Phase 1 | 2024-03-28 |
| Completed | A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943 Obesity | Phase 1 | 2024-03-20 |
| Active Not Recruiting | A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2024-03-19 |
| Active Not Recruiting | Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Type 2 Diabetes | Phase 3 | 2024-03-15 |
| Recruiting | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease Crohn's Disease | Phase 3 | 2024-03-13 |
| Active Not Recruiting | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor | Phase 1 | 2024-03-05 |
| Active Not Recruiting | A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Ad Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | Phase 3 | 2024-03-05 |
| Completed | A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants Healthy | Phase 1 | 2024-03-05 |
| Active Not Recruiting | A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-02-29 |
| Active Not Recruiting | Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glyc Diabetes Mellitus, Type 2 | Phase 3 | 2024-02-21 |
| Completed | A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight Obesity, Overweight and Obesity | Phase 2 | 2024-02-05 |
| Completed | A Relative Bioavailability Study of LY3454738 in Healthy Participants Healthy | Phase 1 | 2024-01-12 |
| Completed | Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment Prostatic Neoplasms | Phase 1 | 2024-01-12 |
| Completed | A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Type 2 Diabetes | Phase 3 | 2024-01-10 |
| Completed | A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants Healthy Male | Phase 1 | 2024-01-03 |
| Completed | A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants Healthy, Obese, Overweight | Phase 1 | 2024-01-02 |
| Recruiting | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With A Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | Phase 3 | 2023-12-21 |
| Completed | A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes Diabetes Mellitus, Type 2 | Phase 1 | 2023-12-07 |
| Recruiting | A Study of LY3971297 in Healthy Participants Healthy, Obesity, Hypertension | Phase 1 | 2023-12-07 |
| Completed | A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis Plaque Psoriasis | Phase 2 | 2023-12-06 |
| Completed | A First-In-Human Study of LY3839840 in Healthy Participants Healthy | Phase 1 | 2023-12-04 |
| Recruiting | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Ulcerative Colitis | Phase 3 | 2023-11-22 |
| Recruiting | A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants W Obesity, Overweight | Phase 2 | 2023-11-17 |
| Completed | A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight Obesity, Overweight and Obesity | Phase 2 | 2023-11-17 |
| Completed | A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Healthy, Type 2 Diabetes Mellitus | Phase 1 | 2023-11-17 |
| Completed | A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Type 2 Diabetes | Phase 3 | 2023-11-10 |
| Terminated | A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis Healthy, Atopic Dermatitis | Phase 1 | 2023-11-01 |
| Completed | A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants Healthy | Phase 1 | 2023-10-27 |
| Completed | A Study of [14C]-LOXO-783 in Healthy Adult Participants Healthy | Phase 1 | 2023-10-23 |
| Active Not Recruiting | A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2023-10-23 |
| Completed | A Phase I Study of LY3502970 in Healthy Participants Healthy | Phase 1 | 2023-10-19 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Obesity, Overweight | Phase 3 | 2023-10-16 |
| Completed | A Study of LY8888AX in Participants Using a Connected Insulin Management Platform Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin | N/A | 2023-10-05 |
| Completed | A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain Diabetic Peripheral Neuropathy | Phase 2 | 2023-10-05 |
| Completed | A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2023-09-28 |
| Completed | A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequatel Type 2 Diabetes | Phase 3 | 2023-09-22 |
| Active Not Recruiting | A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity Type 2 Diabetes, Obesity | Phase 2 | 2023-09-21 |
| Completed | A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Overweight, Obesity | Phase 1 | 2023-09-21 |
| Completed | A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesi Overweight, Obesity | Phase 3 | 2023-09-20 |
| Completed | A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants Healthy | Phase 1 | 2023-09-20 |
| Completed | A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants Healthy | Phase 1 | 2023-09-15 |
| Completed | A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese Overweight | Phase 1 | 2023-09-12 |
| Completed | A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants Healthy | Phase 1 | 2023-09-01 |
| Completed | A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices Healthy | Phase 1 | 2023-08-29 |
| Completed | A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants Healthy | Phase 1 | 2023-08-23 |
| Completed | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) Type 2 Diabetes | Phase 3 | 2023-08-21 |
| Terminated | A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) Dyslipidemias, Non-Alcoholic Fatty Liver Disease | Phase 1 | 2023-08-10 |
| Completed | A Study of LY3871801 in Healthy Asian and Non-Asian Participants Healthy | Phase 1 | 2023-08-09 |
| Completed | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control Type 2 Diabetes | Phase 3 | 2023-08-09 |
| Completed | A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthrit Obesity, Overweight, Osteo Arthritis Knee | Phase 3 | 2023-08-01 |
| Completed | A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease Obesity | Phase 3 | 2023-07-31 |
| Completed | A Study of Tirzepatide (LY3298176) in Healthy Lactating Females Healthy | Phase 1 | 2023-07-31 |
| Completed | A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants Healthy | Phase 1 | 2023-07-27 |
| Completed | A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants Healthy | Phase 1 | 2023-07-21 |
| Completed | A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Ki Overweight or Obesity, CKD, Type 2 Diabetes | Phase 2 | 2023-07-20 |
| Completed | A Study of LY3437943 in Healthy Participants With a High Body Mass Index Healthy | Phase 1 | 2023-07-18 |
| Completed | A Study of LY3437943 in Participants With Impaired and Normal Liver Function Healthy, Hepatic Insufficiency | Phase 1 | 2023-07-13 |
| Completed | A Study of LY3502970 in Participants With Normal and Impaired Renal Function Renal Insufficiency, Healthy | Phase 1 | 2023-07-13 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweigh Type 2 Diabetes, Obesity, Overweight | Phase 3 | 2023-07-11 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight Obesity, Overweight, Osteoarthritis, Knee | Phase 3 | 2023-07-10 |
| Completed | A Study to Compare Two Formulations of LY3819469 in Healthy Participants Healthy | Phase 1 | 2023-06-30 |
| Completed | A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psor Plaque Psoriasis, Psoriatic Arthritis | Phase 4 | 2023-06-27 |
| Completed | A Study to Compare Two Formulations of LY3209590 in Healthy Participants Healthy | Phase 1 | 2023-06-26 |
| Terminated | A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-06-21 |
| Completed | A Study of LY3502970 in Participants With Impaired and Normal Liver Function Healthy, Hepatic Insufficiency | Phase 1 | 2023-06-13 |
| Completed | A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus Diabetes Mellitus, Type 1 | Phase 1 | 2023-06-12 |
| Completed | A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants Healthy | Phase 1 | 2023-06-07 |
| Active Not Recruiting | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comor Obesity, Overweight, Overweight or Obesity | Phase 3 | 2023-06-05 |
| Completed | A Study of [14C]-LY3537982 in Healthy Participants Healthy | Phase 1 | 2023-06-05 |
| Completed | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes Obesity, Overweight, Type 2 Diabetes | Phase 3 | 2023-06-05 |
| Active Not Recruiting | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease Obesity, Cardiovascular Diseases | Phase 3 | 2023-05-30 |
| Recruiting | An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2023-05-23 |
| Active Not Recruiting | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | 2023-05-17 |
| Completed | A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants Healthy | Phase 1 | 2023-05-08 |
| Completed | A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants Healthy, Obese | Phase 1 | 2023-04-26 |
| Completed | A Study of LY3819469 in Participants With Impaired and Normal Renal Function Renal Insufficiency, Healthy | Phase 1 | 2023-04-25 |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbiditie Obesity, Overweight | Phase 3 | 2023-04-21 |
| Recruiting | First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Particip Breast Cancer, Solid Tumors, Adult | Phase 1 / Phase 2 | 2023-04-17 |
| Completed | A Study of the Effect of Food on LY3537982 in Healthy Participants Healthy | Phase 1 | 2023-04-12 |
| Completed | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diab Type 2 Diabetes, Obesity, Overweight or Obesity | Phase 3 | 2023-04-03 |
| Completed | A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices Healthy | Phase 1 | 2023-04-03 |
| Terminated | A Multiple-Dose Study of LY3493269 in Healthy Participants Healthy | Phase 1 | 2023-03-23 |
| Completed | A Study of LY3473329 in Participants With Impaired and Normal Renal Function Renal Insufficiency | Phase 1 | 2023-03-17 |
| Completed | A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants Healthy | Phase 1 | 2023-03-17 |
| Enrolling By Invitation | A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <1 Atopic Dermatitis, Eczema | Phase 3 | 2023-03-09 |
| Completed | A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2) Type 2 Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | 2023-03-08 |
| Active Not Recruiting | A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZ Alzheimer's Disease, Dementia, Brain Diseases | Phase 3 | 2023-02-28 |
| Recruiting | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Areata Alopecia, Alopecia, Hypotrichosis | Phase 3 | 2023-02-27 |
| Completed | A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants Healthy | Phase 1 | 2023-02-24 |
| Completed | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants Healthy | Phase 1 | 2023-02-13 |
| Completed | A Study of LY3848575 in Healthy Participants Healthy | Phase 1 | 2023-02-10 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With Overweight, Obesity, Chronic Kidney Disease | Phase 2 | 2023-02-08 |
| Completed | A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity Obesity | Phase 1 | 2023-02-07 |
| Completed | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders | Phase 3 | 2023-02-05 |
| Terminated | A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HF Heart Failure, Heart Failure With Preserved Ejection Fraction | Phase 2 | 2023-02-03 |
| Completed | A Study of Continuous Blood Pressure Monitoring in Healthy Participants Healthy | N/A | 2023-01-31 |
| Completed | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes W Type 2 Diabetes, T2D | Phase 3 | 2023-01-14 |
| Recruiting | FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms | Phase 1 | 2023-01-12 |
| Completed | A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants Wit Atopic Dermatitis | Phase 3 | 2023-01-12 |
| Completed | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India Diabetes Mellitus, Type 2 | Phase 4 | 2022-12-29 |
| Completed | A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermat Atopic Dermatitis | Phase 3 | 2022-12-19 |
| Completed | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain Chronic Low-back Pain | Phase 2 | 2022-12-08 |
| Completed | A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants Healthy | Phase 1 | 2022-12-05 |
| Completed | A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 1 | 2022-11-30 |
| Completed | A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURP Type 2 Diabetes | Phase 4 | 2022-11-30 |
| Completed | A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events Lipoprotein Disorder | Phase 2 | 2022-11-24 |
| Completed | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain Osteoarthritis | Phase 2 | 2022-11-22 |
| Withdrawn | A Study of LY3526318 in Healthy Male Japanese Participants Healthy | Phase 1 | 2022-11-22 |
| Completed | A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function Healthy, Renal Insufficiency | Phase 1 | 2022-11-16 |
| Completed | Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese Obesity, Obese, Overweight or Obesity | Phase 2 | 2022-11-16 |
| Completed | A Study of LY3305677 in Participants With Obesity Or Overweight Overweight, Obesity | Phase 1 | 2022-11-16 |
| Completed | A Study of Effect of LY3556050 on Metformin in Healthy Participants Healthy | Phase 1 | 2022-11-15 |
| Terminated | A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia Hypertriglyceridemia | Phase 1 | 2022-11-14 |
| Completed | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropath Diabetic Peripheral Neuropathic Pain | Phase 2 | 2022-11-14 |
| Completed | A Study of LY3457263 in Obese Participants Overweight, Obesity | Phase 1 | 2022-11-11 |
| Completed | A Relative Bioavailability Study of LY3209590 in Healthy Participants Healthy | Phase 1 | 2022-11-11 |
| Completed | A Drug Interaction Study of LY3871801 in Healthy Participants Healthy | Phase 1 | 2022-11-02 |
| Completed | A Study of LY3437943 in Chinese Participants With Obesity Or Overweight Overweight, Obesity | Phase 1 | 2022-10-24 |
| Completed | A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] Lipoprotein Disorder | Phase 2 | 2022-10-20 |
| Active Not Recruiting | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopi Atopic Dermatitis, Eczema | Phase 3 | 2022-10-18 |
| Completed | A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants Healthy | Phase 1 | 2022-10-17 |
| Active Not Recruiting | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity Obesity, Overweight | Phase 3 | 2022-10-11 |
| Recruiting | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5 Alzheimer Disease, Dementia, Brain Diseases | Phase 3 | 2022-10-10 |
| Active Not Recruiting | A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer Breast Neoplasms | Phase 1 | 2022-10-09 |
| Completed | A Study of Donanemab (LY3002813) in Healthy Participants Healthy | Phase 1 | 2022-10-04 |
| Active Not Recruiting | A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer Breast Neoplasms | Phase 3 | 2022-10-04 |
| Active Not Recruiting | CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma Sarcoma, Ewing, Neoplasm Metastasis | Phase 2 | 2022-09-20 |
| Completed | A Study of Donanemab (LY3002813) in Healthy Chinese Participants Healthy | Phase 1 | 2022-09-14 |
| Completed | A Study of Imlunestrant (LY3484356) in Healthy Women Healthy | Phase 1 | 2022-09-12 |
| Completed | A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants Healthy | Phase 1 | 2022-08-31 |
| Terminated | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis Rheumatoid Arthritis, Arthritis, Joint Diseases | Phase 2 | 2022-08-31 |
| Completed | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabet Type 1 Diabetes, Diabetes | Phase 3 | 2022-08-12 |
| Completed | A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult P Type 2 Diabetes, Type 2 Diabetes Treated With Insulin | Phase 3 | 2022-08-11 |
| Terminated | A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis Healthy, Dermatitis, Atopic | Phase 1 | 2022-08-11 |
| Completed | A Study of LY3873862 in Healthy Participants Healthy | Phase 1 | 2022-08-11 |
| Completed | A Study of LY3537021 in Healthy Participants Healthy | Phase 1 | 2022-08-08 |
| Active Not Recruiting | A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes Type 2 Diabetes | Phase 4 | 2022-08-01 |
| Completed | A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants Healthy | Phase 1 | 2022-08-01 |
| Active Not Recruiting | A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1) Alzheimer's Disease | Phase 3 | 2022-08-01 |
| Completed | A Study of LY3561774 in Participants With Mixed Dyslipidemia Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases | Phase 2 | 2022-07-20 |
| Completed | A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants Obesity | Phase 1 | 2022-07-08 |
| Completed | A Study of Imlunestrant (LY3484356) in Female Healthy Participants Healthy | Phase 1 | 2022-07-07 |
| Completed | A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function Hepatic Insufficiency, Healthy | Phase 1 | 2022-07-05 |
| Completed | A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants Healthy | Phase 1 | 2022-06-28 |
| Completed | Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstruct Obstructive Sleep Apnea, Obesity | Phase 3 | 2022-06-21 |
| Active Not Recruiting | A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Phase 1 | 2022-06-08 |
| Completed | A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 1 | 2022-06-07 |
| Completed | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Start Diabetes, Type 2 Diabetes | Phase 3 | 2022-06-03 |
| Completed | A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabete Diabetes Mellitus, Type 2 | Phase 1 | 2022-06-02 |
| Completed | A Study of LY3502970 in Healthy Overweight and Obese Participants Healthy, Obese | Phase 1 | 2022-05-26 |
| Completed | A Study of Two Different Formulations of LY3502970 in Healthy Participants Healthy | Phase 1 | 2022-05-17 |
| Active Not Recruiting | A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors Breast Cancer | Phase 1 | 2022-05-11 |
| Completed | A Study of LY3541105 in Healthy and Overweight Participants Overweight, Healthy | Phase 1 | 2022-05-10 |
| Completed | A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) Diabetes Mellitus, Type 2 | Phase 1 | 2022-05-09 |
| Active Not Recruiting | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms | Phase 3 | 2022-04-14 |
| Completed | A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mell Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | 2022-04-13 |
| Completed | A Study of LY3841136 in Healthy and Overweight Participants Obesity, Healthy | Phase 1 | 2022-03-30 |
| Completed | A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes Type 1 Diabetes | Phase 1 | 2022-03-24 |
| Active Not Recruiting | A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Trea Carcinoma, Non-Small-Cell Lung, Thyroid Neoplasms | Phase 1 | 2022-03-23 |
| Completed | A Study of LY3857210 in Healthy Participants Healthy | Phase 1 | 2022-03-17 |
| Active Not Recruiting | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Can Breast Neoplasm, Neoplasm Metastasis | Phase 3 | 2022-03-11 |
| Completed | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabet Type 2 Diabetes | Phase 3 | 2022-03-08 |
| Terminated | A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Er Systemic Lupus Erythematosus | Phase 2 | 2022-03-07 |
| Completed | A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Diabetes Mellitus, Type 1 | Phase 1 | 2022-02-14 |
| Completed | A Study of LY3871801 in Healthy Participants Healthy | Phase 1 | 2022-02-04 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Diabetic Peripheral Neuropathic Pain | Phase 2 | 2022-01-26 |
| Terminated | Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants Healthy | Phase 1 | 2022-01-05 |
| Terminated | A Study of Baricitinib (LY3009104) in Children With COVID-19 Covid19, Corona Virus Infection | Phase 3 | 2021-12-21 |
| Active Not Recruiting | A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 3 | 2021-12-20 |
| Completed | A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine Migraine, Episodic Migraine | Phase 4 | 2021-12-06 |
| Completed | A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy P Healthy Participants | Phase 1 | 2021-11-24 |
| Completed | A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's D Mild Cognitive Impairment (MCI), Alzheimer Disease | Phase 3 | 2021-11-16 |
| Completed | A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 1 | 2021-11-12 |
| Completed | A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants Healthy | Phase 1 | 2021-11-11 |
| Completed | A Study of LY3473329 in Healthy Japanese Participants Healthy | Phase 1 | 2021-11-11 |
| Completed | A Multiple-Dose Study of LY3502970 in Healthy Participants Healthy | Phase 1 | 2021-11-05 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain Chronic Low-back Pain | Phase 2 | 2021-10-25 |
| Completed | A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus Type 1 Diabetes Mellitus | Phase 1 | 2021-10-22 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis Osteoarthritis, Osteo Arthritis Knee | Phase 2 | 2021-10-12 |
| Completed | A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants Healthy | Phase 1 | 2021-10-11 |
| Completed | A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants Healthy | Phase 1 | 2021-10-05 |
| Active Not Recruiting | A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Part Breast Neoplasms, Neoplasm Metastasis | Phase 3 | 2021-10-04 |
| Active Not Recruiting | Study of Oral LOXO-338 in Patients With Advanced Blood Cancers Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin | Phase 1 | 2021-09-30 |
| Completed | A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Obesity, Overweight and Obesity | Phase 2 | 2021-09-29 |
| Completed | A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants Healthy | Phase 1 | 2021-09-28 |
| Completed | A Device Study in Healthy Participants Healthy | Phase 1 | 2021-09-27 |
| Completed | A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease Alzheimer Disease | Phase 2 | 2021-09-16 |
| Completed | A Multiple Dose Study of LY3502970 in Healthy Participants Healthy | Phase 1 | 2021-09-16 |
| Completed | A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 2 | 2021-09-15 |
| Completed | A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overwei Obesity, Overweight, Metabolism and Nutrition Disorder | Phase 3 | 2021-09-01 |
| Active Not Recruiting | A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) Alzheimer Disease | Phase 3 | 2021-08-27 |
| Withdrawn | A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes Type 2 Diabetes, Type 2 Diabetes Treated With Insulin | Phase 4 | 2021-08-16 |
| Completed | A Study of [¹⁴C]-LY3484356 in Healthy Female Participants Healthy | Phase 1 | 2021-08-13 |
| Completed | A Study of LY3361237 in Participants With Psoriasis Psoriasis | Phase 1 | 2021-07-27 |
| Recruiting | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms | Phase 1 / Phase 2 | 2021-07-19 |
| Completed | A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 1 | 2021-07-14 |
| Completed | A Study of LY3819469 in Healthy Participants Healthy | Phase 1 | 2021-06-14 |
| Completed | A Study of LY3532226 in Healthy Participants Healthy | Phase 1 | 2021-06-10 |
| Completed | A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants Healthy | Phase 1 | 2021-06-02 |
| Completed | A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction Chronic Heart Failure With Reduced Ejection Fraction | Phase 1 | 2021-06-01 |
| Recruiting | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases | Phase 3 | 2021-05-26 |
| Completed | A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM) Diabetes Mellitus, Type 2 | Phase 1 | 2021-05-24 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain Chronic Low-back Pain | Phase 2 | 2021-05-20 |
| Completed | A Study of LY3437943 in Participants Who Have Obesity or Are Overweight Obesity, Overweight | Phase 2 | 2021-05-20 |
| Completed | A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell | Phase 2 | 2021-05-14 |
| Completed | A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants Healthy | Phase 1 | 2021-05-14 |
| Completed | A Study of LY3437943 in Participants With Type 2 Diabetes Type 2 Diabetes | Phase 2 | 2021-05-13 |
| Terminated | A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Breast Neoplasms | Phase 3 | 2021-05-10 |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease Obesity | Phase 3 | 2021-05-10 |
| Terminated | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Diabetic Peripheral Neuropathic Pain | Phase 2 | 2021-05-06 |
| Completed | A Study of LY3493269 in Healthy Participants Healthy | Phase 1 | 2021-05-03 |
| Completed | A Study of LY3484356 in Healthy Female Participants Healthy | Phase 1 | 2021-04-26 |
| Completed | A Study of LY3484356 in Women With Breast Cancer Before Having Surgery Breast Cancer | Phase 1 | 2021-04-21 |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) Obesity, Heart Failure With Preserved Ejection Fraction (HFpEF) | Phase 3 | 2021-04-20 |
| Withdrawn | A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2021-04-20 |
| Completed | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders | Phase 3 | 2021-04-13 |
| Active Not Recruiting | A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-rela Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis | Phase 3 | 2021-04-13 |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Lo Obesity, Overweight | Phase 3 | 2021-03-29 |
| Completed | A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program Obesity, Overweight | Phase 3 | 2021-03-29 |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight Type 2 Diabetes, Overweight, Obesity | Phase 3 | 2021-03-29 |
| Completed | A Study of LY3502970 in Healthy Male Participants Healthy | Phase 1 | 2021-03-29 |
| Completed | A Study of LY3540378 in Healthy Participants Healthy | Phase 1 | 2021-03-17 |
| Completed | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Heal Healthy | Phase 1 | 2021-03-11 |
| Completed | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Dermatitis, Atopic, Dermatitis, Eczema | Phase 3 | 2021-03-10 |
| Completed | A Study of Two Different Formulations of LY3209590 in Healthy Participants Healthy | Phase 1 | 2021-03-03 |
| Completed | A Study of LY3410738 in Healthy Adult Participants Healthy | Phase 1 | 2021-02-24 |
| Terminated | A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer Advanced Solid Tumor | Phase 1 | 2021-02-23 |
| Completed | A Study of LY3549492 in Healthy Participants Healthy | Phase 1 | 2021-02-22 |
| Completed | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer Breast Neoplasms, Neoplasm Metastasis | Phase 4 | 2021-02-22 |
| Completed | A Study of Lasmiditan in Healthy Volunteers Healthy | Phase 1 | 2021-02-15 |
| Completed | A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) COVID-19 | Phase 2 | 2021-02-01 |
| Completed | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants Healthy, Renal Insufficiency | Phase 1 | 2021-02-01 |
| Completed | A Study of Continuous Heart Rate Monitoring in Healthy Participants Healthy | N/A | 2021-01-27 |
| Withdrawn | A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes Type 1 Diabetes, Type 2 Diabetes | — | 2021-01-25 |
| Completed | Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-Resistant Prostate Cancer | Phase 2 | 2021-01-20 |
| Completed | A Study to Evaluate LY3154207 on the Brain of Healthy Participants Healthy | Phase 1 | 2021-01-15 |
| Completed | A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9 Healthy | Phase 1 | 2021-01-11 |
| Completed | A Study of LY3462817 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2021-01-04 |
| Completed | A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants Healthy | Phase 1 | 2021-01-04 |
| Completed | A Safety Study of LY3526318 in Healthy Participants Healthy | Phase 1 | 2020-12-29 |
| Completed | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants Healthy, Hepatic Insufficiency | Phase 1 | 2020-12-18 |
| Completed | A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants Healthy | Phase 1 | 2020-12-15 |
| Completed | A Study of LY3537031 in Healthy Participants Healthy | Phase 1 | 2020-12-09 |
| Completed | A Study of LY3041658 in Healthy Participants Healthy | Phase 1 | 2020-12-07 |
| Completed | A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2020-12-07 |
| Completed | A Study of LY3561774 in Participants With Dyslipidemia Dyslipidemias | Phase 1 | 2020-11-30 |
| Active Not Recruiting | A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine Chronic Migraine | Phase 3 | 2020-11-25 |
| Completed | A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes Healthy, Type 2 Diabetes | Phase 1 | 2020-11-25 |
| Completed | A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TR Alzheimer Disease, Dementia, Brain Diseases | Phase 2 | 2020-11-23 |
| Completed | A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus Healthy, Type 2 Diabetes Mellitus | Phase 1 | 2020-11-23 |
| Active Not Recruiting | Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | 2020-11-19 |
| Completed | A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) Atopic Dermatitis | Phase 3 | 2020-11-17 |
| Completed | A Study of LY3451838 in Participants With Migraine Migraine | Phase 2 | 2020-11-16 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis Osteoarthritis | Phase 2 | 2020-11-12 |
| Completed | A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants Healthy | Phase 1 | 2020-11-10 |
| Completed | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adul Relapsed Solid Tumor, Refractory Solid Tumor | Phase 1 / Phase 2 | 2020-11-09 |
| Completed | A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring Type 2 Diabetes | Phase 3 | 2020-11-04 |
| Completed | A Study of Mirikizumab in Healthy Participants Healthy | Phase 1 | 2020-11-02 |
| Completed | A Study of LY3832479 (LY-CoV016) in Healthy Participants 1 Healthy | Phase 1 | 2020-11-02 |
| Completed | A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes Type 1 Diabetes | Phase 2 | 2020-10-30 |
| Completed | A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness COVID-19 | Phase 2 | 2020-10-29 |
| Terminated | A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS Nakajo-Nishimura Syndrome, Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome, STING-Associated Vasculopathy With Onset in Infancy | Phase 2 / Phase 3 | 2020-10-27 |
| Completed | A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 1 | 2020-10-21 |
| Terminated | A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants Healthy | Phase 1 | 2020-10-20 |
| Completed | A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequat Type 2 Diabetes | Phase 3 | 2020-10-19 |
| Completed | A Study of LY3522348 in Healthy Participants Healthy | Phase 1 | 2020-10-15 |
| Completed | A Study of LY3502970 in Participants With Type 2 Diabetes Diabetes Mellitus, Type 2 | Phase 1 | 2020-10-08 |
| Completed | A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb Migraine | Phase 4 | 2020-10-06 |
| Active Not Recruiting | Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations Cholangiocarcinoma, Chondrosarcoma, Glioma | Phase 1 | 2020-10-01 |
| Terminated | Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A Hemophilia A | Phase 1 / Phase 2 | 2020-09-28 |
| Completed | A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants Healthy | Phase 1 | 2020-09-23 |
| Completed | A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide Overweight, Obesity, Diabetes Mellitus, Type 2 | Phase 1 | 2020-09-15 |
| Completed | A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants Healthy | Phase 1 | 2020-09-11 |
| Completed | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Hea Healthy | Phase 1 | 2020-09-03 |
| Completed | A Safety Study of LY3493269 in Healthy Participants Healthy | Phase 1 | 2020-09-03 |
| Completed | A Study of LY3819253 (LY-CoV555) in Healthy Participants Healthy | Phase 1 | 2020-09-02 |
| Completed | A Study of LY3041658 in Adults With Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2020-08-26 |
| Completed | A Study of LY3493269 in Participants With Type 2 Diabetes Diabetes Mellitus, Type 2 | Phase 1 | 2020-08-25 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain Chronic Low-back Pain | Phase 2 | 2020-08-25 |
| Completed | A Study of Tirzepatide in Overweight and Very Overweight Participants Obesity, Overweight | Phase 1 | 2020-08-24 |
| Completed | A Study of LY3473329 in Healthy Participants Healthy | Phase 1 | 2020-08-18 |
| Completed | A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants Healthy | Phase 1 | 2020-08-14 |
| Completed | A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants Healthy | Phase 1 | 2020-08-06 |
| Completed | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in COVID-19, SARS-CoV2 | Phase 3 | 2020-08-02 |
| Completed | A Study of Ramucirumab (LY3009806) in Healthy Participants Healthy | Phase 1 | 2020-07-30 |
| Completed | Study of Tirzepatide in Healthy Participants Healthy | Phase 1 | 2020-07-28 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Diabetic Peripheral Neuropathic Pain | Phase 2 | 2020-07-15 |
| Completed | A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes Type 1 Diabetes, Type 2 Diabetes | N/A | 2020-07-14 |
| Completed | A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide Obesity | Phase 1 | 2020-07-09 |
| Completed | A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants Alzheimer Disease, Healthy | Phase 1 | 2020-07-07 |
| Completed | A Study of LY3209590 in Participants With Type 1 Diabetes Type 1 Diabetes Mellitus | Phase 2 | 2020-07-06 |
| Completed | A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2020-07-01 |
| Completed | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis Osteoarthritis | Phase 2 | 2020-07-01 |
| Terminated | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine Migraine | Phase 3 | 2020-06-30 |
| Active Not Recruiting | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease Crohn's Disease | Phase 3 | 2020-06-22 |
| Completed | A Study of LY3832479 (LY-CoV016) in Healthy Participants Healthy | Phase 1 | 2020-06-19 |
| Active Not Recruiting | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Alzheimer Disease | Phase 3 | 2020-06-19 |
| Completed | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illn COVID-19 | Phase 2 / Phase 3 | 2020-06-17 |
| Completed | A Study of LY3461767 in Healthy Participants Healthy | Phase 1 | 2020-06-15 |
| Terminated | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine Migraine | Phase 3 | 2020-06-15 |
| Completed | Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Atopic Dermatitis | Phase 3 | 2020-06-15 |
| Completed | A Study of Baricitinib (LY3009104) in Participants With COVID-19 COVID-19 | Phase 3 | 2020-06-12 |
| Active Not Recruiting | A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma Neuroblastoma | Phase 1 | 2020-06-11 |
| Completed | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants Wi Type 2 Diabetes Mellitus | Phase 3 | 2020-05-29 |
| Completed | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 COVID-19 | Phase 1 | 2020-05-28 |
| Completed | A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Ulcerative Colitis | Phase 2 | 2020-05-18 |
| Terminated | A Study of LY3127804 in Participants With COVID-19 COVID-19, Pneumonia | Phase 2 | 2020-04-20 |
| Completed | A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis Spondyloarthritis | Phase 3 | 2020-04-10 |
| Completed | A Study of LY3478045 in Healthy Participants Healthy | Phase 1 | 2020-03-16 |
| Active Not Recruiting | A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumor, Medullary Thyroid Cancer | Phase 2 | 2020-03-16 |
| Terminated | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma Synovial Sarcoma | Phase 1 / Phase 2 | 2020-03-04 |
| Completed | A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 1 | 2020-02-28 |
| Completed | A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participant Healthy | Phase 1 | 2020-02-26 |
| Completed | A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes W Diabetes Mellitus, Type 1 | Phase 1 | 2020-02-25 |
| Completed | A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2, Hypoglycemia | Phase 1 | 2020-02-24 |
| Active Not Recruiting | A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Non-Small Cell Lung Cancer | Phase 3 | 2020-02-17 |
| Terminated | A Study of LY3478006 in Healthy Participants Healthy | Phase 1 | 2020-02-17 |
| Completed | A Study of Baricitinib in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2020-02-14 |
| Recruiting | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenil Systemic Juvenile Idiopathic Arthritis | Phase 3 | 2020-02-12 |
| Completed | Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-t Atopic Dermatitis | Phase 3 | 2020-02-11 |